Elicio Therapeutics: Preclinical Data from Lymph Node-Targeting COVID-19 Vaccine Indicate Potent T-cell and Antibody Responses – CBI
Homepage /  Press Release /  Elicio Therapeutics: Preclinical Data from Lymph Node-Targeting COVID-19 Vaccine Indicate Potent T-cell and Antibody Responses

Press Release

Elicio Therapeutics: Preclinical Data from Lymph Node-Targeting COVID-19 Vaccine Indicate Potent T-cell and Antibody Responses